Loading company…
Solve Therapeutics develops antibody-drug conjugates for complex diseases.
Founded in 2021 and based in Alameda, US, Solve Therapeutics develops antibody-drug conjugates for a range of diseases. In November 2025, it raised USD 120.00 mn led by Yosemite Management, bringing its total funding to USD 120.00 mn.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in